Mobile Health (mHealth) Adverse-Event Reporting Apps Market Report 2026

The mobile health (mhealth) adverse-event reporting apps market size has grown rapidly in recent years. It will grow from $1.84 billion in 2025 to $2.19 billion in 2026 at a compound annual growth rate (CAGR) of 18.5%. The growth in the historic period can be attributed to increasing smartphone penetration in healthcare, expansion of pharmacovigilance regulations, growth of digital health platforms, rising focus on patient safety monitoring, increasing clinical trial digitization.

The mobile health (mhealth) adverse-event reporting apps market size is expected to see rapid growth in the next few years. It will grow to $4.27 billion in 2030 at a compound annual growth rate (CAGR) of 18.2%. The growth in the forecast period can be attributed to increasing adoption of ai-driven safety analytics, rising demand for real-time drug safety surveillance, expansion of decentralized clinical trials, growing regulatory emphasis on post-market surveillance, increasing integration of mhealth platforms in healthcare systems. Major trends in the forecast period include increasing adoption of real-time adverse event reporting, growing integration with electronic health records, expansion of patient-centric safety reporting interfaces, rising use of automated signal detection tools, enhanced focus on regulatory-compliant data capture.

The expansion of remote patient monitoring is expected to drive the growth of the mobile health (mHealth) adverse-event reporting apps market going forward. Remote patient monitoring collects health data outside traditional settings. Its expansion is driven by chronic disease prevalence and the need for continuous monitoring. This supports adverse-event reporting apps by enabling real-time data capture and timely reporting of treatment side effects. For instance, in June 2025, remote patient monitoring services reached over 5.1 million in physician offices. Therefore, the expansion of remote patient monitoring is driving the growth of mHealth adverse-event reporting apps.

The rising smartphone penetration is expected to drive the growth of the mobile health (mHealth) adverse-event reporting apps market going forward. Smartphone penetration refers to the proportion of the population that owns and uses smartphones, reflecting the broad adoption and integration of mobile technology into everyday life. Increasing smartphone penetration is driven by improved affordability and greater accessibility of mobile devices across emerging markets. High levels of smartphone penetration enable broader access, faster incident reporting, and real-time communication, making mobile health adverse-event reporting apps more efficient and scalable. For instance, in February 2023, according to the GSM Association (GSMA), a UK-based industry organization representing mobile network operators and related companies, smartphone penetration in sub-Saharan Africa is projected to increase significantly, reaching 87% by 2030, up from 51% in 2022. Therefore, increasing smartphone penetration is supporting the growth of the mobile health (mHealth) adverse-event reporting apps market.

Leading companies operating in the mobile health (mHealth) adverse-event reporting apps market are focusing on developing advanced solutions such as mobile-based communication tools to accelerate adverse-event detection and improve overall drug safety monitoring. Mobile-based communication tools are digital platforms that enable seamless interaction, reporting, and information sharing through smartphones or tablets, supporting real-time connectivity between patients, healthcare providers, and regulators. For instance, in September 2023, Bharat Serums and Vaccines Limited (BSV), an India-based biopharmaceutical company, launched BSV AER, a mobile-based communication application that enables healthcare professionals, consumers, and company personnel to electronically report potential adverse events related to BSV products across India at no cost. The app integrates directly with BSV’s pharmacovigilance system to support timely evaluation and efficient management of adverse events.

Major companies operating in the mobile health (mhealth) adverse-event reporting apps market are IQVIA Holdings Inc., Veeva Systems Inc., ArisGlobal LLC, SafetyCall International PLLC, Medwatcher, Advera Health Analytics Inc., Itransition Group Inc., Saama Technologies Inc., Optimal Strategix Group Inc., OSP Labs Private Limited, K Health Inc., Healthy.io Ltd., InPhase Technologies Ltd., Tiga Healthcare Technologies Inc., Qualityze Inc., iVigee Services AS, Preventice Solutions Inc., Luscii Healthtech BV, My Mhealth Limited, Med.

North America was the largest region in the mobile health (mHealth) adverse event reporting apps market in 2025. The regions covered in the mobile health (mhealth) adverse-event reporting apps market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the mobile health (mhealth) adverse-event reporting apps market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are impacting the mHealth adverse-event reporting apps market by increasing costs associated with imported servers, cloud infrastructure components, cybersecurity tools, and mobile development frameworks used to build and deploy compliant applications. Healthcare providers and pharmaceutical companies in North America and Europe are most affected due to reliance on cross-border digital infrastructure and third-party technology services, while Asia-Pacific faces cost pressures in application deployment and maintenance. These tariffs are raising operational expenses and slowing large-scale platform rollouts. However, they are also encouraging regional data hosting, local software development, and stronger domestic digital health ecosystems.

The mobile health (mhealth) adverse-event reporting apps market research report is one of a series of new reports that provides mobile health (mhealth) adverse-event reporting apps market statistics, including mobile health (mhealth) adverse-event reporting apps industry global market size, regional shares, competitors with a mobile health (mhealth) adverse-event reporting apps market share, detailed mobile health (mhealth) adverse-event reporting apps market segments, market trends and opportunities, and any further data you may need to thrive in the mobile health (mhealth) adverse-event reporting apps industry. This mobile health (mhealth) adverse-event reporting apps market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Mobile health (mHealth) adverse-event reporting apps are mobile applications that utilize smartphones or tablets to collect, document, and transmit information regarding adverse reactions to medications, devices, or treatments. They support real-time safety data reporting, ensuring quicker communication among stakeholders. These apps enhance pharmacovigilance by simplifying data collection, improving transparency, and reducing delays in identifying potential risks.

The primary app types of mobile health (mHealth) adverse event reporting apps are standalone adverse-event reporting apps and integrated mHealth platforms. Standalone adverse-event reporting apps are mobile or web-based applications developed exclusively for reporting adverse events, enabling healthcare professionals or patients to securely and efficiently submit information regarding drug reactions or medical incidents. These platforms include Android, iOS, and web-based systems and are used in applications such as pharmacovigilance, clinical trials, patient safety monitoring, and others by end-users including hospitals and clinics, pharmaceutical companies, research organizations, patients, and others.

The mobile health (mHealth) adverse event reporting apps market includes revenues earned by entities through real-time data transmission, pharmacovigilance support, analytics and reporting, and regulatory compliance. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.